Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Other financing activities (2018 - 2025)

Historic Other financing activities for ImmunoTech (AIM) over the last 7 years, with Q1 2025 value amounting to $60000.0.

  • ImmunoTech's Other financing activities fell 2500.0% to $60000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $470000.0, marking a year-over-year decrease of 3047.34%. This contributed to the annual value of $250000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, ImmunoTech's Other financing activities is $60000.0, which was down 2500.0% from $330000.0 recorded in Q3 2024.
  • In the past 5 years, ImmunoTech's Other financing activities registered a high of $330000.0 during Q3 2024, and its lowest value of $60000.0 during Q1 2025.